Pulse Biosciences passes enrollment midpoint in atrial fibrillation study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. META
10. AMC

Go back to Pulse Biosciences passes enrollment midpoint in atrial fibrillation study
(NASDAQ: PLSE) Delayed: 53.31 -0.56 (1.04%)
Previous Close $53.87    52 Week High $6.77 
Open $53.97    52 Week Low $4.03 
Day High $54.81    P/E N/A 
Day Low $51.74    EPS $0.00 
Volume 382,256